20 results
6-K
TAK
Takeda Pharmaceutical Co
17 Jun 24
Current report (foreign)
6:46am
in the responder rate, measures of caregiver and clinician global impression of improvement, and seizure intensity and duration scales over the 16-week treatment … impression of improvement, and seizure intensity and duration scales over the 16-week treatment period. Further analyses are being conducted
6-K
EX-99.1
TAK
Takeda Pharmaceutical Co
29 May 24
Current report (foreign)
6:24am
:
- 45 - – The vaccine to be considered for introduction in settings with high dengue disease burden and high transmission intensity to maximize
6-K
TAK
Takeda Pharmaceutical Co
2 Feb 24
Current report (foreign)
6:16am
in settings with high dengue disease burden and high transmission intensity to maximize the public health impact and minimize any potential risk
6-K
EX-99.1
TAK
Takeda Pharmaceutical Co
30 Nov 23
Current report (foreign)
6:01am
in the U.S. in prior year, increasing global competitive intensity, and pricing headwinds in EUCAN. In the U.S., ENTYVIO maintains the lead as #1 in both IBD
6-K
TAK
Takeda Pharmaceutical Co
30 Oct 23
Current report (foreign)
6:02am
transmission intensity to maximize the public health impact and minimize any potential risk in seronegative persons.
–The vaccine to be introduced
6-K
EX-99.1
nqoyae7l8n0aoexv2
23 Jun 23
Current report (foreign)
6:13am
6-K
EX-99.1
1393tdaj
30 May 23
Current report (foreign)
6:11am
6-K
EX-99.1
ozvicopcy9t71mzry
6 Apr 21
Current report (foreign)
6:29am
6-K
EX-99.1
vpshpobq6jcd3jws4
8 Dec 20
Current report (foreign)
6:01am
424B3
2tub o9dv
14 Nov 19
Prospectus supplement
6:10am
F-4/A
j1lkl46vgm0
12 Nov 19
Registration of securities (foreign) (amended)
9:50am
F-4
mihtc35zy6x8qme
9 Aug 19
Registration of securities (foreign)
6:27am
20-F
yeprlr4m
27 Jun 19
Annual report (foreign)
6:41am
20FR12B/A
ld4xtd4xwmf5 kqrzv
17 Dec 18
Initial registration of securities (foreign private issuers) (amended)
6:14am
20FR12B
djy nqqpk
6 Dec 18
Initial registration of securities (foreign private issuers)
10:39am
DRS/A
j911h2wr 4jz5slh
16 Nov 18
Draft registration statement (amended)
12:00am
- Prev
- 1
- Next